MEGGAN SHEA: Open Payments
NPI 1013268564 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,897 in 84 payments from 18 companies in 2025. Trend: 2023 $1,245 · 2024 $1,789 · 2025 $1,897
Food & beverage: $1,897
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $381 |
| Lilly USA, LLC | 8 | $254 |
| ABBVIE INC. | 9 | $187 |
| Novo Nordisk Inc | 13 | $180 |
| Exact Sciences Corporation | 5 | $121 |
| PFIZER INC. | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| SHIELD THERAPEUTICS INC | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| GlaxoSmithKline, LLC. | 5 | $81 |
Products named: AIRSUPRA, REXULTI, VRAYLAR, MOUNJARO, FARXIGA, The Cologuard Plus Collection Kit, ZEPBOUND, ACCRUFER.
Industry payments across NY — which companies pay providers there.
